Affirm's Optimistic News Clashes with DeepValue's Risk-Focused Sell Thesis

What happened

A Seeking Alpha article from March 2026 asserts that Affirm's stock has bottomed, citing twice-raised FY2026 guidance, robust merchant and consumer acquisition trends, and higher margins. The article highlights strong year-to-date performance, discounted forward P/E of 14.91x, and technical indicators suggesting oversold conditions with potential upside to price targets up to $113.20. However, the latest DeepValue master report maintains a 'POTENTIAL SELL' stance, acknowledging Affirm's impressive growth and profitability but warning of overvaluation at 104x TTM P/E and a 204% premium to DCF intrinsic value. The report emphasizes critical risks including high leverage with Net Debt/EBITDA of 9.13x, thin interest coverage of 0.34x, sector delinquencies near 30%, and regulatory uncertainty from the CFPB. Consequently, while the news paints a bullish recovery narrative, the fundamental analysis underscores that underlying vulnerabilities in credit, funding, and regulation could quickly undermine any short-term gains.

Implication

Short-term traders might be tempted by the discounted multiples and oversold technical indicators highlighted in the news, but long-term investors must critically assess whether the raised guidance reflects sustainable improvements or temporary optimism. Affirm's heavy reliance on securitizations and institutional funding leaves it exposed to credit market shocks, which could pressure growth and profitability if delinquencies rise or funding costs increase. Regulatory changes, such as potential CFPB rules treating BNPL like credit cards, could compress margins and raise compliance costs, further straining the business model in a competitive sector. The stock's lofty valuation multiples, including 104x TTM P/E and 43x EV/EBITDA, already price in a flawless execution scenario, offering little margin of safety if any risks materialize. Therefore, unless there is concrete evidence of improved balance sheet health, stabilized credit metrics, and favorable regulatory outcomes, the risk/reward profile remains unfavorable for value-oriented investors, aligning with the DeepValue sell thesis.

Thesis delta

The optimistic news article does not materially alter the DeepValue 'POTENTIAL SELL' thesis, as the raised guidance and acquisition trends fail to address the core risks of high leverage, sector-wide credit issues, and regulatory uncertainty highlighted in the report. If anything, the emphasis on higher margins may be overstated given the cyclical nature of BNPL and intense competition, which could pressure long-term profitability. Thus, the thesis remains unchanged, with a sell recommendation until there is demonstrable progress in reducing leverage, improving interest coverage, and achieving regulatory clarity.